Hutch News

Stories tagged 'merkel cell carcinoma'

Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma

May 31, 2017 | By Rachel Tompa / Fred Hutch News Service

In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.

View story >


With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma

April 3, 2017 | By Susan Keown / Fred Hutch News Service

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 31, 2017

Dr. Philip Greenberg elected to serve on AACR board of directors; five researchers receive awards to explore immunotherapy single-cell RNA sequencing.

View story >


Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer

Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma

March 24, 2017 | by Susan Keown / Fred Hutch News Service

Tom Judd's metastatic Merkel cell carcinoma nearly took his life. But then he enrolled on a trial of an experimental immunotherapy drug.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 2, 2017

Novel gene therapy for sickle cell disease and related disorders on the horizon; immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care; Dr. Cara McDermott receives AcademyHealth new investigator award; and study documents sperm changes years after chemotherapy.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 19, 2017

Dr. Larry Corey wins $2.6 million grant to explore using CAR T cells for HIV cure; Immune responses against virus-related cancer may provide clues for improved immunotherapy; Hutch/UW symposium underscores Seattle's reputation as "infectious disease central"; Fred Hutch CIO Matthew Trunnell among speakers at SLU Collaborative seminar.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.